Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01663467
Recruitment Status : Withdrawn (there was no participants who were enrolled in this study)
First Posted : August 13, 2012
Last Update Posted : October 25, 2016
Sponsor:
Collaborator:
Soonchunhyang University Hospital
Information provided by (Responsible Party):
YOUNG HO KIM, Seoul National University Hospital

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to prove the efficacy of the internet and smartphone application-delivered tinnitus retraining therapy (TRT).

Condition or disease Intervention/treatment Phase
Tinnitus Drug: Ginkgo biloba Behavioral: modified TRT Not Applicable

Detailed Description:
to investigate the effect of TRT with minimized counseling
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Efficacy of Internet and Smartphone Application-delivered TRT
Study Start Date : September 2014
Actual Primary Completion Date : September 2016
Actual Study Completion Date : September 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tinnitus

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Active Comparator: Ginkgo biloba only
control group Ginexin-F 80mg tablet will be given twice a day for 6 months.
 Drug: Ginkgo biloba
Ginexin-F 80mg tablet will be given twice a day for 6 months.
Other Name: Ginexin-F
Experimental: Ginkgo biloba + modified TRT

experimental group modified TRT (tinnitus retraining therapy) using smartphone and web based materials will be added with Ginkgo biloba.

Ginexin-F 80mg tablet will be given twice a day for 6 months.

 Drug: Ginkgo biloba
Ginexin-F 80mg tablet will be given twice a day for 6 months.
Other Name: Ginexin-F

Behavioral: modified TRT

modified TRT (tinnitus retraining therapy) using smartphone and web based materials will be added with Ginkgo biloba.

Ginexin-F 80mg tablet will be given twice a day for 6 months.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Tinnitus Handicap Inventory (THI) [ Time Frame: 6 months ]
    THI will be evaluated 6 months after TRT using smatrphone and web


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • chronic subjective tinnitus

Exclusion Criteria:

  • THI < 18
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01663467


Locations
Layout table for location information
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 156-707
Sponsors and Collaborators
Seoul National University Hospital
Soonchunhyang University Hospital
Investigators
Layout table for investigator information
Study Chair: YOUNG HO KIM, MD., PhD Seoul National University Hospital
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: YOUNG HO KIM, Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Boramae Medical Center, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT01663467    
Other Study ID Numbers: SNUH_YHK_TRT
First Posted: August 13, 2012    Key Record Dates
Last Update Posted: October 25, 2016
Last Verified: October 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by YOUNG HO KIM, Seoul National University Hospital:
tinnitus
smartphone
Web
Additional relevant MeSH terms:
Layout table for MeSH terms
Tinnitus
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
 Sensation Disorders
Neurologic Manifestations
Nervous System Diseases